EX-99.2H.1 8 formn2exhh1_021908.htm Exhibit h.1


                                                                Exhibit h.1

                       TORTOISE ENERGY CAPITAL CORPORATION
                            (a Maryland Corporation)
                        __________ Shares of Common Stock
                           Par Value $_____ Per Share

                             UNDERWRITING AGREEMENT



                                ----------, ----

Ladies and Gentlemen:

     Tortoise Energy Capital Corporation, a Maryland corporation (the "FUND"),
and the Fund's investment adviser, Tortoise Capital Advisors, LLC, a Delaware
limited liability company (the "ADVISER"), each confirms its agreement with
____________, _____________ and each of the other Underwriters named in Schedule
A hereto (collectively, the "UNDERWRITERS"), for whom ________________ and
_________________ are acting as representatives (in such capacity, the
"REPRESENTATIVES"), with respect to the issue and sale by the Fund and the
purchase by the Underwriters, acting severally and not jointly, of the
respective number of shares of common stock, par value $____ per share, of the
Fund ("COMMON SHARES") set forth in Schedule A hereof (collectively, the
"PRIMARY SHARES"), and with respect to the grant by the Fund to the
Underwriters, acting severally and not jointly, of the option described in
Section 2(b) hereof to purchase all or any part of _______ additional Common
Shares to cover over-allotments, if any (the "OPTION SHARES"). The Primary
Shares and the Option Shares are collectively referred to as the "SHARES."

     The Fund understands that the Underwriters propose to make a public
offering of the Shares as soon as the Representatives deem advisable after this
Agreement has been executed and delivered.

     The Fund has filed with the Securities and Exchange Commission (the
"COMMISSION") a registration statement on Form N-2 (File Nos. 333-131204 and
811-21462) which became effective on __________, ____ and a related preliminary
prospectus supplement, covering the registration of the Shares under the
Securities Act of 1933, as amended (the "1933 ACT"), and a notification on Form
N-8A of registration of the Fund as an investment company under the Investment
Company Act of 1940, as amended (the "1940 ACT"), and the rules and regulations
of the Commission under the 1933 Act and the 1940 Act (the "RULES AND
REGULATIONS"). Promptly after execution and delivery of this Agreement, the Fund
will prepare and file a post-effective amendment and a prospectus supplement in
accordance with the provisions of Rule 430A ("RULE 430A") and paragraph (c)
and/or (h) of Rule 497 ("RULE 497") of the Rules and Regulations. The
information included in any such prospectus that was omitted from such
registration statement at the time it became effective but that is deemed to be
part of such registration statement at the time it became effective pursuant to
paragraph (b) of Rule 430A is referred to as "RULE 430A INFORMATION." Each
prospectus used before such registration statement became effective, and any
prospectus that omitted the Rule 430A Information that was used after such
effectiveness and prior to the execution and delivery of this Agreement,
including in each case any statement of additional information incorporated
therein by reference, is herein called a "PRELIMINARY PROSPECTUS." Such
registration statement, including the amendments thereto, the exhibits and
schedules thereto at the time it became effective and including the Rule 430A
Information and any statement of additional information incorporated therein by
reference, is herein called the "REGISTRATION STATEMENT." Any registration
statement filed pursuant to Rule 462(b) of the Rules and Regulations is herein
referred to as the "RULE 462(B) REGISTRATION STATEMENT," and



the term "REGISTRATION STATEMENT" shall include any Rule 462(b) Registration
Statement that shall have been filed. The final prospectus in the form first
furnished to the Underwriters for use in connection with the offering of the
Shares, including the statement of additional information incorporated therein
by reference, is herein called the "PROSPECTUS." For purposes of this Agreement,
all references to the Registration Statement, any preliminary prospectus, the
Prospectus or any amendment or supplement to any of the foregoing shall be
deemed to include the copy filed with the Commission pursuant to its Electronic
Data Gathering, Analysis and Retrieval system ("EDGAR").

     All references in this Agreement to financial statements and schedules and
other information which is "contained," "included" or "stated" in the
Registration Statement, any preliminary prospectus or the Prospectus (or other
references of like import) shall be deemed to mean and include all such
financial statements and schedules and other information which are incorporated
by reference in the Registration Statement, any preliminary prospectus or the
Prospectus, as the case may be.

     Section 1. Representations and Warranties.

          (a) Representations and Warranties by the Fund and the Adviser. The
     Fund and the Adviser represent and warrant to each Underwriter as of the
     date hereof, as of the Applicable Time (as defined below), as of the
     Closing Time referred to in Section 2(c) hereof, and as of each Date of
     Delivery (if any) referred to in Section 2(b) hereof, and agree with each
     Underwriter, as follows:

               (i) Compliance With Registration Requirements. Each of the
          Registration Statement and any Rule 462(b) Registration Statement has
          become effective under the 1933 Act and no stop order suspending the
          effectiveness of the Registration Statement or any Rule 462(b)
          Registration Statement has been issued under the 1933 Act, or order of
          suspension or revocation of registration pursuant to Section 8(e) of
          the 1940 Act, and no proceedings for any such purpose, have been
          instituted or are pending or, to the knowledge of the Fund or the
          Adviser, are contemplated by the Commission, and any request on the
          part of the Commission for additional information has been complied
          with.

               At the respective times the Registration Statement, any Rule
          462(b) Registration Statement and any post-effective amendment thereto
          (filed before the Closing Time) became effective and at the Closing
          Time, as hereinafter defined (and, if any Option Shares are purchased,
          at the Date of Delivery), the Registration Statement, the Rule 462(b)
          Registration Statement, the notification of Form N-8A and all
          amendments and supplements thereto complied and will comply in all
          material respects with the requirements of the 1933 Act, the 1940 Act
          and the Rules and Regulations and did not and will not contain an
          untrue statement of a material fact or omit to state a material fact
          required to be stated therein or necessary to make the statements
          therein not misleading. Neither the Prospectus nor any amendment or
          supplement thereto, at the time the Prospectus or any such amendment
          or supplement was issued and at the Closing Time (and, if any Option
          Shares are purchased, at the Date of Delivery), included or will
          include an untrue statement of a material fact or omitted or will omit
          to state a material fact necessary in order to make the statements
          therein, in the light of the circumstances under which they were made,
          not misleading. The representations and warranties in this subsection
          shall not apply to statements in or omissions from the Registration
          Statement or Prospectus made in reliance upon and in conformity with
          written information furnished to the Fund by or on behalf of any
          Underwriter for use in the Registration Statement or Prospectus.

               As of the Applicable Time (as defined below), the Rule 482
          Statement (as defined below) issued at or prior to the Applicable
          Time, if any, the Statutory Prospectus (as defined below) and the
          information included on Schedule C hereto, all considered together
          (collectively, the



          "GENERAL DISCLOSURE PACKAGE"), did not include any untrue statement of
          a material fact or omitted to state any material fact necessary in
          order to make the statements therein, in the light of the
          circumstances under which they were made, not misleading.

               As used in this subsection and elsewhere in this Agreement:

               "Applicable Time" means 5:30 p.m. (Eastern time) on __________,
          ____ or such other time as agreed by the Fund and the Representatives.

               "Rule 482 Statement" means a document prepared in accordance with
          the provisions of Rule 482 of the 1933 Act in connection with the
          offering of the Shares and which is set forth on Schedule D hereto.

               "Statutory Prospectus" as of any time means the prospectus
          relating to the Shares that is included in the Registration Statement
          immediately prior to that time, including any document incorporated by
          reference therein.

               Each preliminary prospectus and the prospectus filed as part of
          the Registration Statement as originally filed or as part of any
          amendment thereto, or filed pursuant to Rule 497 under the 1933 Act,
          complied when so filed in all material respects with the Rules and
          Regulations and each preliminary prospectus and the Prospectus
          delivered to the Underwriters for use in connection with this offering
          was identical to the electronically transmitted copies thereof filed
          with the Commission pursuant to EDGAR, except to the extent permitted
          by Regulation S T.

               If a Rule 462(b) Registration Statement is required in connection
          with the offering and sale of the Shares, the Fund has complied or
          will comply with the requirements of Rule 111 under the 1933 Act
          Regulations relating to the payment of filing fees thereof.

               At the time of filing the Registration Statement, any 462(b)
          Registration Statement and any post-effective amendments thereto and
          at the date hereof, the Fund was not and is not an "ineligible
          issuer," as defined in Rule 405 of the Rules and Regulations.

                    (ii) Incorporation of Documents by Reference. The documents
               incorporated in the Registration Statement, the Prospectus and
               the Statutory Prospectus, at the time they were or hereafter are
               filed with the Commission, complied and will comply in all
               material respects with the requirements of the 1934 Act and the
               rules and regulations of the Commission under the 1934 Act, the
               1940 Act and the Rules and Regulations and, when read together
               with the other information in the Prospectus, (a) at the time the
               Registration Statement became effective, (b) at the time the
               Prospectus was issued and (c) at the Closing Time, did not and
               will not contain an untrue statement of a material fact or omit
               to state a material fact required to be stated therein or
               necessary to make the statements therein not misleading.

                    (iii) Independent Accountants. The accountants who certified
               the statement of assets and liabilities included in the
               Registration Statement have confirmed to the Fund their status as
               independent public accountants as required by the 1933 Act and
               the Rules and Regulations and the Fund and the Adviser have no
               reason to believe that they are not independent public
               accountants.

                    (iv) Financial Statements. The statement of assets and
               liabilities included in the Registration Statement, the General
               Disclosure Package and the Prospectus, together with the related
               notes, presents fairly in accordance with generally accepted
               accounting principles





               ("GAAP") in all material respects the financial position of the
               Fund at the date indicated and has been prepared in conformity
               with GAAP. The supporting schedules, if any, present fairly in
               accordance with GAAP the information required to be stated
               therein. The selected financial data and the summary financial
               information included in the Prospectus present fairly the
               information shown therein and have been compiled on a basis
               consistent with that of audited financial statements included in
               the Registration Statement.

                    (v) Expense Summary. The information set forth in the
               Prospectus in the fee table contained in the section of the
               Prospectus entitled "Summary of Company Expenses" has been
               prepared in all material respects in accordance with the
               requirements of Form N-2, and interpretations thereunder, and to
               the extent estimated or projected, such estimates or projections
               are reasonably believed to be attainable and reasonably based.

                    (vi) No Material Adverse Change. Since the respective dates
               as of which information is given in the Registration Statement,
               the General Disclosure Package and the Prospectus, except as
               otherwise stated therein, (A) there has been no material adverse
               change in the condition, financial or otherwise, or in the
               earnings, business affairs or business prospects of the Fund,
               whether or not arising in the ordinary course of business (other
               than as a result of changes in market conditions generally) (a
               "MATERIAL ADVERSE EFFECT"), (B) there have been no transactions
               entered into by the Fund, other than those in the ordinary course
               of business, which are material with respect to the Fund, and (C)
               there has been no dividend or distribution of any kind declared,
               paid or made by the Fund on any class of its capital stock.

                    (vii) Good Standing of the Fund. The Fund has been duly
               organized and is validly existing as a corporation in good
               standing under the laws of the State of Maryland and has the
               corporate power and authority to own, lease and operate its
               properties and to conduct its business as described in the
               Prospectus and to enter into and perform its obligations under
               this Agreement; and the Fund is duly qualified as a foreign
               corporation to transact business and is in good standing in each
               other jurisdiction in which such qualification is required,
               whether by reason of the ownership or leasing of property or the
               conduct of business, except where the failure so to qualify or to
               be in good standing would not result in a Material Adverse
               Effect.

                    (viii) No Subsidiaries. The Fund has no subsidiaries.

                    (ix) Investment Company Status. The Fund is duly registered
               with the Commission under the 1940 Act as a nondiversified,
               closed end management investment company, and no order of
               suspension or revocation of such registration has been issued or
               proceedings therefor initiated or, to the Fund's knowledge,
               threatened by the Commission.

                    (x) Officers and Directors. No person is serving or acting
               as an officer, director or investment adviser of the Fund except
               in accordance with the provisions of the 1940 Act and the Rules
               and Regulations and the Investment Advisers Act of 1940, as
               amended (the "ADVISERS ACT"), and the rules and regulations of
               the Commission promulgated under the Advisers Act (the "ADVISERS
               ACT RULES AND REGULATIONS"). Except as disclosed in the
               Registration Statement, the General Disclosure Package and the
               Prospectus, to the Fund's knowledge after due inquiry, no
               director of the Fund is an "Interested Person" (as defined in the
               1940 Act) of the Fund or an "Affiliated Person" (as defined in
               the 1940 Act) of any Underwriter that serves as a Representative.

                    (xi) Capitalization. The authorized, issued and outstanding
               capital stock of the Fund is as set forth in the General
               Disclosure Package and the Prospectus as of the date thereof
               under the captions "The Company" and "Description of Securities."
               All issued



               and outstanding Common Shares of the Fund and all issued and
               outstanding Money Market Cumulative Preferred Shares of the Fund
               (the "PREFERRED SHARES") have been duly authorized and validly
               issued and are fully paid and non-assessable, and have been
               offered and sold or exchanged by the Fund in compliance with all
               applicable laws (including, without limitation, federal and state
               securities laws). None of the outstanding Common Shares or
               Preferred Shares of the Fund was issued in violation of the
               preemptive or other similar rights of any securityholder of the
               Fund.

                    (xii) Authorization and Description of Shares. The Shares to
               be purchased by the Underwriters from the Fund have been duly
               authorized for issuance and sale to the Underwriters pursuant to
               this Agreement and, when issued and delivered by the Fund
               pursuant to this Agreement against payment of the consideration
               set forth herein, will be validly issued, fully paid and
               non-assessable. The Common Shares conform to all statements
               relating thereto contained in the General Disclosure Package and
               the Prospectus and such description conforms in all material
               respects to the rights set forth in the instruments defining the
               same; and the issuance of the Shares is not subject to the
               preemptive or other similar rights of any securityholder of the
               Fund.

                    (xiii) Absence of Defaults and Conflicts. The Fund is not in
               violation of its charter or by-laws, or in default in the
               performance or observance of any obligation, agreement, covenant
               or condition contained in any material contract, indenture,
               mortgage, deed of trust, loan or credit agreement, note, lease or
               other agreement or instrument to which it is a party or by which
               it may be bound, or to which any of the property or assets of the
               Fund is subject (collectively, "AGREEMENTS AND INSTRUMENTS")
               except for such violations or defaults that would not result in a
               Material Adverse Effect; and the execution, delivery and
               performance of this Agreement, the Investment Advisory Agreement,
               the Custody Agreement, the Stock Transfer Agency Agreement, the
               Fund Administration Servicing Agreement and the Fund Accounting
               Servicing Agreement referred to in the Registration Statement (as
               used herein, individually the "Investment Advisory Agreement,"
               the "Custody Agreement," the "Stock Transfer Agency Agreement,"
               the "Fund Administration Servicing Agreement," and the "Fund
               Accounting Servicing Agreement," respectively and collectively
               the "OFFERING AGREEMENTS") and the consummation of the
               transactions contemplated in the Offering Agreements and in the
               Registration Statement (including the issuance and sale of the
               Shares and the use of the proceeds from the sale of the Shares as
               described in the General Disclosure Package and the Prospectus
               under the caption "Use of Proceeds") and compliance by the Fund
               with its obligations thereunder have been duly authorized by all
               necessary corporate action and do not and will not, whether with
               or without the giving of notice or passage of time or both,
               conflict with or constitute a breach of, or default or Repayment
               Event (as defined below) under, or result in the creation or
               imposition of any lien, charge or encumbrance upon any property
               or assets of the Fund pursuant to, the Agreements and Instruments
               (except for such conflicts, breaches or defaults or liens,
               charges or encumbrances that would not result in a Material
               Adverse Effect), nor will such action result in any violation of
               the provisions of the charter or by-laws of the Fund or any
               applicable law, statute, rule, regulation, judgment, order, writ
               or decree of any government, government instrumentality or court,
               domestic or foreign, having jurisdiction over the Fund or any of
               its assets, properties or operations (except for such violations
               that would not result in a Material Adverse Effect). As used
               herein, a "REPAYMENT EVENT" means any event or condition which
               gives the holder of any note, debenture or other evidence of
               indebtedness (or any person acting on such holder's behalf) the
               right to require the repurchase, redemption or repayment of all
               or a portion of such indebtedness by the Fund.




                    (xiv) Absence of Proceedings. There is no action, suit,
               proceeding, inquiry or investigation before or brought by any
               court or governmental agency or body, domestic or foreign, now
               pending, or, to the knowledge of the Fund or the Adviser,
               threatened, against or affecting the Fund, which is required to
               be disclosed in the Registration Statement (other than as
               disclosed therein), or which could reasonably be expected to
               result in a Material Adverse Effect, or which could reasonably be
               expected to materially and adversely affect the properties or
               assets of the Fund or the consummation of the transactions
               contemplated in this Agreement or the performance by the Fund of
               its obligations hereunder. The aggregate of all pending legal or
               governmental proceedings to which the Fund is a party or of which
               any of its property or assets is the subject which are not
               described in the Registration Statement, including ordinary
               routine litigation incidental to the business, could not
               reasonably be expected to result in a Material Adverse Effect.

                    (xv) Accuracy of Exhibits. There are no contracts or
               documents which are required to be described in the Registration
               Statement or the Prospectus (or the documents incorporated by
               reference therein) or to be filed as exhibits thereto by the 1933
               Act, the 1940 Act or by the Rules and Regulations which have not
               been so described and filed as required.

                    (xvi) Possession of Intellectual Property; Fund Name. The
               Fund owns or possesses, or can acquire on reasonable terms,
               adequate licenses, copyrights, know-how (including trade secrets
               or confidential information, systems or procedures), trademarks,
               service marks, trade names or other intellectual property
               (collectively, "INTELLECTUAL PROPERTY") necessary to carry on the
               business now operated by the Fund, and the Fund has not received
               any notice or is not otherwise aware of any infringement of or
               conflict with asserted rights of others with respect to any
               Intellectual Property or of any facts or circumstances which
               would render any Intellectual Property invalid or inadequate to
               protect the interest of the Fund therein.

                    (xvii) Absence of Further Requirements. No filing with, or
               authorization, approval, consent, license, order, registration,
               qualification or decree of, any court or governmental authority
               or agency is necessary or required for the performance by the
               Fund of its obligations hereunder, in connection with the
               offering, issuance or sale of the Shares hereunder or the
               consummation of the transactions contemplated by this Agreement,
               except such as have been already obtained or as may be required
               under the 1933 Act, the 1940 Act, the Securities Exchange Act of
               1934, as amended (the "1934 ACT"), or under the rules of the New
               York Stock Exchange ("NYSE") or the NASD, Inc. ("NASD") or state
               securities laws. In furtherance of the foregoing, the Fund
               represents and warrants that it has previously filed, in
               consultation with the Underwriters, with the NASD all Rule 482
               Statements which are required to be filed with the NASD.

                    (xviii) Possession of Licenses and Permits. The Fund
               possesses such permits, licenses, approvals, consents and other
               authorizations (collectively, "GOVERNMENTAL LICENSES") issued by
               the appropriate federal, state, local or foreign regulatory
               agencies or bodies necessary to operate its properties and to
               conduct the business as contemplated in the Prospectus. The Fund
               is in compliance with the terms and conditions of all such
               Governmental Licenses, except where the failure so to comply
               would not, singly or in the aggregate, have a Material Adverse
               Effect. All of the Governmental Licenses are valid and in full
               force and effect, except when the invalidity of such Governmental
               Licenses or the failure of such Governmental Licenses to be in
               full force and effect would not have a Material Adverse Effect.
               The Fund has not received any notice of proceedings relating to
               the revocation or modification of any such Governmental Licenses.



                    (xix) Advertisements. Any advertising, sales literature or
               other promotional material (including "prospectus wrappers,"
               "broker kits," "road show slides" and "road show scripts" and
               "electronic road show presentations"), including, without
               limitation, the "investor guide" prepared by the Fund and dated
               __________ ____ entitled "Add-On Offering of Common Stock (NYSE:
               TYY)," authorized in writing by or prepared by the Fund or the
               Adviser used in connection with the public offering of the Shares
               (collectively, "SALES MATERIAL") does not contain an untrue
               statement of a material fact or omit to state a material fact
               required to be stated therein or necessary to make the statements
               therein in light of the circumstances under which they were made
               not misleading. Moreover, all Sales Material complied and will
               comply in all material respects with the applicable requirements
               of the 1933 Act, the 1940 Act, the Rules and Regulations and the
               rules and interpretations of the NASD (except that this
               representation and warranty does not apply to statements in or
               omissions from the Sales Material made in reliance upon and in
               conformity with written information relating to any Underwriter
               furnished to the Fund by or on behalf of any Underwriter through
               you expressly for use therein), including any requirement to file
               any Rule 482 Statement.

                    (xx) Subchapter M. The Fund has not made and will not make
               an election under Section 851(b) of the Internal Revenue Code of
               1986, as amended (the "CODE") (or any successor provisions
               thereto), to be treated as a regulated investment company for
               federal income tax purposes.

                    (xxi) Distribution of Offering Materials. The Fund has not
               distributed and, prior to the later of (A) the Closing Time and
               (B) completion of the distribution of the Shares, will not
               distribute any offering material to the public in connection with
               the offering and sale of the Shares other than the Registration
               Statement, the Statutory Prospectus, the Rule 482 Statement and
               the Prospectus.

                    (xxii) Accounting Controls and Disclosure Controls. The Fund
               maintains a system of internal accounting controls sufficient to
               provide reasonable assurances that (A) transactions are executed
               in accordance with management's general or specific authorization
               and with the applicable requirements of the 1940 Act, the Rules
               and Regulations, the NASD and the Code; (B) transactions are
               recorded as necessary to permit preparation of financial
               statements in conformity with generally accepted accounting
               principles and to maintain accountability for assets and to
               maintain compliance with the books and records requirements under
               the 1940 Act and the Rules and Regulations; (C) access to assets
               is permitted only in accordance with the management's general or
               specific authorization; and (D) the recorded accountability for
               assets is compared with existing assets at reasonable intervals
               and appropriate action is taken with respect to any differences.
               The Fund has developed and maintains disclosure controls and
               procedures (as such term is defined in Rule 30a-3 of the 1940
               Act) that are effective in ensuring that information required to
               be disclosed by the Fund in the reports that it files or submits
               under the 1940 Act is recorded, processed, summarized and
               reported, within the time periods specified in the rules and
               forms of the Commission, including, without limitation, controls
               and procedures designed to ensure that information required to be
               disclosed by the Fund in the reports that it files or submits
               under the 1940 Act is accumulated and communicated to the Fund's
               management, including its principal executive officer or officers
               and its principal financial officer or officers, as appropriate
               to allow timely decisions regarding required disclosure.

                    (xxiii) Absence of Undisclosed Payments. Neither the Fund
               nor, to the Fund's Knowledge, any employee or agent of the Fund,
               has made any payment of funds of the Fund or received or retained
               any funds, which payment, receipt or retention of funds is of a
               character required to be disclosed in the Prospectus and which
               payment has not been so disclosed.



                    (xxiv) Material Agreements. The Offering Agreements have
               each been duly authorized by all requisite action on the part of
               the Fund and executed and delivered by the Fund, as of the dates
               noted therein, and each complies with all applicable provisions
               of the 1940 Act in all material respects. Assuming due
               authorization, execution and delivery by the other parties
               thereto with respect to this Agreement and the other Offering
               Agreements, each Offering Agreement constitutes a valid and
               binding agreement of the Fund, enforceable in accordance with its
               terms, except as affected by bankruptcy, insolvency, fraudulent
               conveyance, reorganization, moratorium and other similar laws
               relating to or affecting creditors' rights generally, general
               equitable principles (whether considered in a proceeding in
               equity or at law) and an implied covenant of good faith and fair
               dealing and except as rights to indemnification or contribution
               thereunder may be limited by federal or state laws.

                    (xxv) Registration Rights. There are no persons with
               registration rights or other similar rights to have any
               securities registered pursuant to the Registration Statement or
               otherwise registered by the Fund under the 1933 Act.

                    (xxvi) NYSE Listing. The Shares have been duly authorized
               for listing, upon notice of issuance, on the NYSE and the Fund's
               registration statement on Form 8 A under the 1934 Act has become
               effective.

                    (xxvii) Payment of Taxes. All United States federal income
               tax returns of the Fund required by law to be filed have been
               filed and all taxes shown by such returns or otherwise assessed,
               which are due and payable, have been paid, except assessments
               that are being contested in good faith and as to which adequate
               reserves have been provided. The United States federal income tax
               returns of the Fund through the fiscal year ended __________,
               ____ have been settled and no assessment in connection therewith
               has been made against the Fund. The Fund has filed all other tax
               returns that are required to have been filed by them pursuant to
               applicable foreign, state, local or other law except insofar as
               the failure to file such returns would not result in a Material
               Adverse Effect, and has paid all taxes due pursuant to such
               returns or pursuant to any assessment received by the Fund,
               except for such taxes, if any, as are being contested in good
               faith and as to which adequate reserves have been provided. The
               charges, accruals and reserves on the books of the Fund in
               respect of any income and corporation tax liability for any years
               not finally determined are adequate to meet any assessments or
               re-assessments for additional tax for any years not finally
               determined, except to the extent of any inadequacy that would not
               result in a Material Adverse Effect. All material taxes which the
               Fund is required by law to withhold or to collect for payment
               have been duly withheld and collected and have been paid to the
               appropriate governmental authority or agency or have been
               accrued, reserved against and entered on the books of the Fund.

                    (xxviii) Insurance. The Fund carries on or is entitled to
               the benefits of insurance, with financially sound and reputable
               insurers, in such amounts and covering such risks as are
               generally maintained by companies of established repute engaged
               in the same or similar business, and all such insurance is in
               full force and effect. The Fund has no reason to believe that it
               will not be able to (A) renew its existing insurance coverage as
               and when such policies expire or (B) obtain comparable coverage
               from similar institutions as may be necessary or appropriate to
               conduct its business as now conducted and at a cost that would
               not result in a Material Adverse Effect.

                    (xxix) Statistical and Market-Related Data. Any statistical
               and market-related data included in the Registration Statement,
               the General Disclosure Package and the



               Prospectus are based on or derived from sources that the Fund
               believes to be reliable and accurate, and the Fund has obtained
               written consent to the use of such data from such sources.

          (b) Representations and Warranties by the Adviser. The Adviser
     represents and warrants to each Underwriter as of the date hereof, as of
     the Applicable Time, as of the Closing Time referred to in Section 2(c)
     hereof, and as of each Date of Delivery (if any) referred to in Section
     2(b) hereof as follows:

               (i) Good Standing of the Adviser. The Adviser has been duly
          organized and is validly existing and in good standing as a limited
          liability company under the laws of the State of Delaware with full
          power and authority to own, lease and operate its properties and to
          conduct its business as described in the General Disclosure Package
          and the Prospectus and is duly qualified as a foreign entity to
          transact business and is in good standing in each other jurisdiction
          in which such qualification is required except as would not,
          individually or in the aggregate, result in a material adverse change
          in the condition, financial or otherwise, or in the earnings, business
          affairs or business prospects of such Adviser, whether or not arising
          in the ordinary course of business (an "ADVISER MATERIAL ADVERSE
          EFFECT").

               (ii) Investment Adviser Status. The Adviser is duly registered
          and in good standing with the Commission as an investment adviser
          under the Advisers Act, and is not prohibited by the Advisers Act, the
          1940 Act, or the rules and regulations under such acts, from acting
          under the Investment Advisory Agreement for the Fund as contemplated
          by the Prospectus.

               (iii) Description of Adviser. The description of the Adviser in
          the Registration Statement, the General Disclosure Package and the
          Prospectus (including any amendment or supplement thereto) complied
          and comply in all material respects with the provisions of the 1933
          Act, the 1940 Act, the Advisers Act, the Rules and Regulations and the
          Advisers Act Rules and Regulations and is true and correct and does
          not contain any untrue statement of a material fact or omit to state
          any material fact required to be stated therein or necessary in order
          to make the statements therein, in light of the circumstances under
          which they were made, not misleading.

               (iv) Capitalization. The Adviser has the financial resources
          available to it necessary for the performance of its services and
          obligations as contemplated in the General Disclosure Package,
          Prospectus and in the Offering Agreements.

               (v) Authorization of Offering Agreements; Absence of Defaults and
          Conflicts. This Agreement and the Investment Advisory Agreement have
          each been duly authorized, executed and delivered by the Adviser, and
          (assuming the due authorization, execution and delivery of each other
          party thereto) each such Agreement constitutes a valid and binding
          obligation of the Adviser, enforceable in accordance with its terms,
          except as affected by bankruptcy, insolvency, fraudulent conveyance,
          reorganization, moratorium and other similar laws relating to or
          affecting creditors' rights generally and general equitable principles
          (whether considered in a proceeding in equity or at law) or an implied
          covenant of good faith and fair dealing and except as rights to
          indemnification or contribution thereunder may be limited by federal
          or state laws; and neither the execution and delivery of this
          Agreement or the Investment Advisory Agreement nor the performance by
          the Adviser of its obligations hereunder or thereunder will conflict
          with, or result in a breach of any of the terms and provisions of, or
          constitute, with or without the giving of notice or lapse of time or
          both, a default under, (i) any agreement or instrument to which the
          Adviser is a party or by which it is bound, (ii) the limited liability
          company operating agreement and other organizational documents of the
          Adviser, or (iii) to the Adviser's knowledge, by any law, order,
          decree, rule or regulation applicable to it of



          any jurisdiction, court, federal or state regulatory body,
          administrative agency or other governmental body, stock exchange or
          securities association having jurisdiction over the Adviser or its
          properties or operations other than any conflict, breach or default
          that would not, individually or in the aggregate, reasonably be
          expected to result in an Adviser Material Adverse Effect; and no
          consent, approval, authorization or order of any court or governmental
          authority or agency is required for the consummation by the Adviser of
          the transactions contemplated by this Agreement or the Investment
          Advisory Agreement, except as have been obtained or will be obtained
          prior to the Closing Time or may be required under the 1933 Act, the
          1940 Act, the 1934 Act or state securities laws.

               (vi) No Material Adverse Change. Since the respective dates as of
          which information is given in the Registration Statement, the General
          Disclosure Package and the Prospectus, there has not occurred any
          event which could reasonably be expected to have a material adverse
          effect on the ability of the Adviser to perform its respective
          obligations under this Agreement and the Investment Advisory
          Agreement.

               (vii) Absence of Proceedings. There is no action, suit,
          proceeding, inquiry or investigation before or brought by any court or
          governmental agency or body, domestic or foreign, now pending, or, to
          the knowledge of the Adviser, threatened against or affecting the
          Adviser or any "affiliated person" of the Adviser (as such term is
          defined in the 1940 Act) or any partners, directors, officers or
          employees of the foregoing, whether or not arising in the ordinary
          course of business, which could reasonably be expected to result in
          Adviser Material Adverse Effect or, materially and adversely affect
          the ability of the Adviser to function as an investment adviser with
          respect to the Fund or perform its obligations under this Agreement or
          the Investment Advisory Agreement, or which is required to be
          disclosed in the Registration Statement and the Prospectus.

               (viii) Absence of Violation or Default. The Adviser is not in
          violation of its limited liability company operating agreement or
          other organizational documents or in default under any agreement,
          indenture or instrument, except for such violations or defaults that
          have not and could not result in an Adviser Material Adverse Effect.

          (c) Officer's Certificates. Any certificate signed by any officer of
     the Fund or the Adviser delivered to the Representatives or to counsel for
     the Underwriters shall be deemed a representation and warranty by the Fund
     or the Adviser, as the case may be, to each Underwriter as to the matters
     covered thereby.

     Section 2. Sale and Delivery To Underwriters; Closing.

          (a) Primary Shares. On the basis of the representations, warranties
     and covenants contained herein and subject to the terms and conditions set
     forth herein, the Fund agrees to sell to each Underwriter, severally and
     not jointly, and each Underwriter, severally and not jointly, agrees to
     purchase from the Fund, at the price per share set forth in Schedule B, the
     number of Primary Shares set forth in Schedule A opposite the name of such
     Underwriter, plus any additional number of Primary Shares which such
     Underwriter may become obligated to purchase pursuant to the provisions of
     Section 10 hereof.

          (b) Option Shares. In addition, on the basis of the representations
     and warranties contained herein and subject to the terms and conditions set
     forth herein, the Fund hereby grants an option to the Underwriters,
     severally and not jointly, to purchase up to an additional _______ Common
     Shares in the aggregate at the price per share set forth in Schedule B,
     less an amount per share equal to any dividends or distributions declared
     by the Fund and payable on the Primary Shares but not payable on the Option
     Shares. The option hereby granted will expire 45 days after the date hereof
     and may be exercised



     in whole or in part from time to time only for the purpose of covering
     over-allotments which may be made in connection with the offering and
     distribution of the Primary Shares upon notice by the Representatives to
     the Fund setting forth the number of Option Shares as to which the several
     Underwriters are then exercising the option and the time and date of
     payment and delivery for such Option Shares. Any such time and date of
     delivery (a "DATE OF DELIVERY") shall be determined by the Representatives,
     but shall not be later than seven (7) full business days and no earlier
     than three (3) full business days after the exercise of said option, nor in
     any event prior to the Closing Time. If the option is exercised as to all
     or any portion of the Option Shares, each of the Underwriters, acting
     severally and not jointly, will purchase that proportion of the total
     number of Option Shares then being purchased which the number of Primary
     Shares set forth in Schedule A opposite the name of such Underwriter bears
     to the total number of Primary Shares, subject in each case to such
     adjustments as Merill Lynch in its discretion shall make to eliminate any
     sales or purchases of a fractional number of Option Shares plus any
     additional number of Option Shares which such Underwriter may become
     obligated to purchase pursuant to the provisions of Section 10 hereof.

          (c) Payment. Payment of the purchase price for, and delivery of
     certificates for, the Primary Shares shall be made at the offices of Kaye
     Scholer LLP, 425 Park Avenue, New York, New York 10022 or at such other
     place as shall be agreed upon by the Representatives and the Fund, at 10:00
     A.M. (Eastern time) on the third business day after the date hereof (unless
     postponed in accordance with the provisions of Section 10), or such other
     time not later than ten (10) business days after such date as shall be
     agreed upon by the Representatives and the Fund (such time and date of
     payment and delivery being herein called "CLOSING TIME"). In addition, in
     the event that any or all of the Option Shares are purchased by the
     Underwriters, payment of the purchase price for such Option Shares shall be
     made at the above-mentioned offices, or at such other place as shall be
     agreed upon by the Representatives and the Fund, on each Date of Delivery
     as specified in the notice from the Representatives to the Fund.

          Payment shall be made to the Fund by wire transfer of immediately
     available funds to a bank account designated by the Fund, against delivery
     to the Representatives for the respective accounts of the Underwriters of
     the Shares to be purchased by them. It is understood that each Underwriter
     has authorized the Representatives, for its account, to accept delivery of,
     receipt for, and make payment of the purchase price for, the Primary Shares
     and the Option Shares, if any, which it has agreed to purchase.
     _______________, individually and not as representative of the
     Underwriters, may (but shall not be obligated to) make payment of the
     purchase price for the Primary Shares or the Option Shares, if any, to be
     purchased by any Underwriter whose funds have not been received by the
     Closing Time or the relevant Date of Delivery, as the case may be, but such
     payment shall not relieve such Underwriter from its obligations hereunder.

          (d) Denominations; Registration. Certificates for the Primary Shares
     and the Option Shares, if any, shall be in such denominations and
     registered in such names as the Representatives may request in writing at
     least three (3) full business days before the Closing Time or the relevant
     Date of Delivery, as the case may be. The certificates for the Primary
     Shares and the Option Shares, if the Fund determines to issue any such
     certificates, will be made available for examination and packaging by the
     Representatives in the City of New York not later than 10:00 A.M. (Eastern
     time) on the business day prior to the Closing Time or the relevant Date of
     Delivery, as the case may be. The Primary Shares and the Option Shares to
     be purchased hereunder shall be delivered to you at the Closing Time or the
     relevant Date of Delivery, as the case may be, through the facilities of
     the Depository Trust Company or another mutually agreeable facility,
     against payment of the purchase price therefor in immediately available
     funds to the order of the Fund.



     Section 3. Covenants.

          (a) The Fund and Adviser covenant with each Underwriter as follows:

               (i) Compliance With Securities Regulations and Commission
          Requests. The Fund, subject to Section 3(a)(ii), will comply with the
          requirements of Rule 430A or Rule 430C, as applicable, and will notify
          the Representatives as soon as practicable, and confirm the notice in
          writing, (i) when any post-effective amendment to the Registration
          Statement shall become effective, or any supplement to the Prospectus
          or any amended Prospectus shall have been filed, (ii) of the receipt
          of any comments from the Commission, (iii) of any request by the
          Commission for any amendment to the Registration Statement or any
          amendment or supplement to the Prospectus (or any document
          incorporated by reference therein) or for additional information, (iv)
          of the issuance by the Commission of any stop order suspending the
          effectiveness of the Registration Statement or of any order preventing
          or suspending the use of any preliminary prospectus, or of the
          suspension of the qualification of the Shares for offering or sale in
          any jurisdiction, or of the initiation or threatening of any
          proceedings for any of such purposes or of any examination pursuant to
          Section 8(e) of the 1933 Act concerning the Registration Statement,
          and (v) if the Fund becomes the subject of a proceeding under Section
          8A of the 1933 Act in connection with the offering of the Shares. The
          Fund will promptly effect the necessary post-effective amendment and
          the filings required pursuant to Rule 497 and will take such steps as
          it deems necessary to ascertain promptly whether the form of
          prospectus transmitted for filing under Rule 497 was received for
          filing by the Commission and, in the event that it was not, it will
          promptly file such prospectus. The Fund will make every reasonable
          effort to prevent the issuance of any stop order, or order of
          suspension or revocation of registration pursuant to Section 8(e) of
          the 1940 Act, and, if any such stop order or order of suspension or
          revocation of registration is issued, to obtain the lifting thereof at
          the earliest possible moment.

               (ii) Filing of Amendments and Exchange Act Documents. The Fund
          will give the Representatives notice of its intention to file or
          prepare any amendment to the Registration Statement (including any
          filing under Rule 462(b)) or any amendment, supplement or revision to
          either the prospectus included in the Registration Statement at the
          time it became effective or to the Prospectus, and will furnish the
          Representatives with copies of any such documents a reasonable amount
          of time prior to such proposed filing or use, as the case may be, and
          will not file or use any such documents to which the Representatives
          or counsel for the Underwriters shall reasonably object. The Fund has
          given the Representatives notice of any filings made pursuant to the
          1934 Act or the rules and regulations of the Commission under the 1934
          Act (the "1934 ACT REGULATIONS") within 48 hours prior to the
          Applicable Time; the Fund will give the Representatives notice of its
          intention to make any such filing from the Applicable Time to the
          Closing Time and will furnish the Representatives with copies of any
          such documents a reasonable amount of time prior to such proposed
          filing, or as the case may be, and will not file or use any such
          document to which the Representatives or counsel for the Underwriters
          shall object; provided, however that this covenant shall not apply to
          any post-effective amendment required by Rule 8b-16 of the 1940 Act
          which is filed with the Commission after the later of (x) one year
          from the date of this Agreement or (y) the date on which the
          distribution of the Shares is completed.

               (iii) Delivery of Registration Statements. The Fund has furnished
          or will deliver to the Representatives and counsel for the
          Underwriters, without charge, signed copies of the Registration
          Statement as originally filed and of each amendment thereto (including
          exhibits filed therewith or incorporated by reference therein and
          documents incorporated by reference therein) and signed copies of all
          consents and certificates of experts, and will also deliver to the



          Representatives, without charge, a conformed copy of the Registration
          Statement as originally filed and of each amendment (except any
          post-effective amendment required by Rule 8b-16 of the 1940 Act which
          is filed with the Commission after the later of (x) one year from the
          date of this Agreement or (y) the date on which the distribution of
          the Shares is completed) thereto (without exhibits) for each of the
          Underwriters. The copies of the Registration Statement and each
          amendment thereto furnished to the Underwriters will be identical to
          the electronically transmitted copies thereof filed with the
          Commission pursuant to EDGAR, except to the extent permitted by
          Regulation S T.

               (iv) Delivery of Prospectuses. The Fund has delivered to each
          Underwriter, without charge, as many copies of each preliminary
          prospectus as such Underwriter reasonably requested, and the Fund
          hereby consents to the use of such copies for purposes permitted by
          the 1933 Act. The Fund will furnish to each Underwriter, without
          charge, during the period when the Prospectus is required to be
          delivered under the 1933 Act or the 1934 Act, such number of copies of
          the Prospectus (as amended or supplemented) as such Underwriter may
          reasonably request. The Prospectus and any amendments or supplements
          thereto furnished to the Underwriters will be identical to the
          electronically transmitted copies thereof filed with the Commission
          pursuant to EDGAR, except to the extent permitted by Regulation S-T.

               (v) Continued Compliance With Securities Laws. If at any time
          when a prospectus is required by the 1933 Act to be delivered in
          connection with sales of the Shares, any event shall occur or
          condition shall exist as a result of which it is necessary, in the
          reasonable opinion of counsel for the Underwriters or for the Fund, to
          amend the Registration Statement or amend or supplement the Prospectus
          in order that the Prospectus will not include any untrue statements of
          a material fact or omit to state a material fact necessary in order to
          make the statements therein not misleading in the light of the
          circumstances existing at the time it is delivered to a purchaser, or
          if it shall be necessary, in the opinion of such counsel, at any such
          time to amend the Registration Statement or amend or supplement the
          Prospectus in order to comply with the requirements of the 1933 Act or
          the Rules and Regulations, the Fund will promptly prepare and file
          with the Commission, subject to Section 3(a)(ii), such amendment or
          supplement as may be necessary to correct such statement or omission
          or to make the Registration Statement or the Prospectus comply with
          such requirements, and the Fund will furnish to the Underwriters such
          number of copies of such amendment or supplement as the Underwriters
          may reasonably request. If at any time following issuance of a Rule
          482 Statement, there occurred or occurs an event or development as a
          result of which such Rule 482 Statement conflicted with or would
          conflict with the information contained in the Registration Statement
          (or any other registration statement relating to the Shares) or the
          Statutory Prospectus or any preliminary prospectus, or such Rule 482
          Statement included or would include an untrue statement of a material
          fact or omitted or would omit to state a material fact necessary in
          order to make the statements therein, in the light of the
          circumstances, prevailing at the subsequent time, not misleading, the
          Fund will promptly notify the Representatives and will promptly amend
          or supplement, at its own expense, such Rule 482 Statement to
          eliminate or correct such conflict, untrue statement or omission.

               (vi) Blue Sky Qualifications. The Fund will use its best efforts,
          in cooperation with the Underwriters, to qualify the Shares for
          offering and sale under the applicable securities laws of such states
          and other jurisdictions of the United States as the Representatives
          may designate and to maintain such qualifications in effect so long as
          required for the distribution of the Shares; provided, however, that
          the foregoing shall not apply to the extent that the Shares are
          "covered securities" that are exempt from state regulation of
          securities offerings pursuant to Section 18 of the 1933 Act; and
          provided, further, that the Fund shall not be obligated to file any



          general consent to service of process or to qualify as a foreign
          corporation or as a dealer in securities in any jurisdiction in which
          it is not so qualified or to subject itself to taxation in respect of
          doing business in any jurisdiction in which it is not otherwise so
          subject.

               (vii) Rule 158. The Fund will timely file such reports pursuant
          to the 1934 Act as are necessary in order to make generally available
          to its securityholders as soon as practicable an earnings statement
          for the purposes of, and to provide to the Underwriters the benefits
          contemplated by, the last paragraph of Section 11(a) of the 1933 Act.

               (viii) Use of Proceeds. The Fund will use the net proceeds
          received by it from the sale of the Shares in the manner specified in
          the General Disclosure Package and the Prospectus under "Use of
          Proceeds."

               (ix) Listing. The Fund will use its best efforts to effect the
          listing of the Shares on the NYSE, subject to notice of issuance.

               (x) Restriction on Sale of Shares. During a period of 90 days
          from the date of the Prospectus, the Fund will not, without the prior
          written consent of _____________, (A) directly or indirectly, offer,
          pledge, sell, contract to sell, sell any option or contract to
          purchase, purchase any option or contract to sell, grant any option,
          right or warrant to purchase or otherwise transfer or dispose of
          Common Shares or any securities convertible into or exercisable or
          exchangeable for Common Shares or file any registration statement
          under the 1933 Act with respect to any of the foregoing or (B) enter
          into any swap or any other agreement or any transaction that
          transfers, in whole or in part, directly or indirectly, the economic
          consequence of ownership of the Common Shares, whether any such swap
          or transaction described in clause (A) or (B) above is to be settled
          by delivery of Common Shares or such other securities, in cash or
          otherwise. The foregoing sentence shall not apply to the Shares to be
          sold hereunder or the Common Shares issued pursuant to any dividend
          reinvestment plan.

               (xi) Reporting Requirements. The Fund, during the period when the
          Prospectus is required to be delivered under the 1933 Act or the 1934
          Act, will file all documents required to be filed with the Commission
          pursuant to the 1940 Act and the 1934 Act within the time periods
          required by the 1940 Act and the Rules and Regulations and the 1934
          Act and the rules and regulations of the Commission thereunder,
          respectively.

               (xii) No Manipulation of Market for Shares. Except for the
          authorization of actions permitted to be taken by the Underwriters as
          contemplated herein, in the General Disclosure Package or in the
          Prospectus, the Fund will not (a) take, directly or indirectly, any
          action designed to cause or to result in, or that might reasonably be
          expected to constitute, the stabilization or manipulation of the price
          of any security of the Fund to facilitate the sale or resale of the
          Shares in violation of federal or state securities laws, and (b) until
          the Closing Time, or the Date of Delivery, if any, (i) except for
          Share repurchases permitted in accordance with applicable laws and
          issuances of Shares or purchases of Shares in the open market pursuant
          to the Fund's dividend reinvestment plan, sell, bid for or purchase
          the Shares or pay any person any compensation for soliciting purchases
          of the Shares or (ii) pay or agree to pay to any person any
          compensation for soliciting another to purchase any other securities
          of the Fund.

               (xiii) Rule 462(b) Registration Statement. If the Fund elects to
          rely upon Rule 462(b), the Fund shall file a Rule 462(b) Registration
          Statement with the Commission in compliance with Rule 462(b) by 10:00
          P.M., Washington, D.C. time, on the date of this Agreement, and the
          Fund shall at the time of filing either pay to the Commission the
          filing fee for



          the Rule 462(b) Registration Statement or give irrevocable
          instructions for the payment of such fee pursuant to Rule 111(b) under
          the 1933 Act.

               (xiv) Sales Materials. The Fund represents and agrees that,
          unless it obtains the prior consent of the Representatives, it will
          not use any Sales Materials in connection with any public offering of
          any Shares.

     Section 4. Payment of Expenses.

          (a) Expenses. The Fund will pay all expenses incident to the
     performance of its obligations under this Agreement, including (i) the
     preparation, printing and filing of the Registration Statement (including
     financial statements and exhibits) as originally filed and of each
     amendment thereto, (ii) the preparation, printing and delivery to the
     Underwriters of this Agreement, any agreement among Underwriters and such
     other documents as may be required in connection with the offering,
     purchase, sale, issuance or delivery of the Shares, (iii) the preparation,
     issuance and delivery of the certificates for the Shares to the
     Underwriters, including any stock or other transfer taxes and any stamp or
     other duties payable upon the sale, issuance or delivery of the Shares to
     the Underwriters, (iv) the fees and disbursements of the Fund's counsel,
     accountants and other advisers, (v) the printing and delivery to the
     Underwriters of copies of each preliminary prospectus, any Rule 482
     Statement and of the Prospectus and any amendments or supplements thereto
     and any costs associated with electronic delivery of any of the foregoing
     by the Underwriters to investors, (vi) the fees and expenses of any
     transfer agent or registrar for the Shares, (vii) the filing fees incident
     to, and the reasonable fees and disbursements of counsel to the
     Underwriters in connection with, the review by the NASD of the terms of the
     sale of the Shares, (viii) the fees and expenses incurred in connection
     with the listing of the Shares on the NYSE, (ix) the printing of any Sales
     Material and (x) the fees and expenses (including, without limitation, any
     damages or other amounts payable in connection with legal or contractual
     liability) associated with the reforming of any contracts for sale of the
     Shares made by the Underwriters caused by a breach of the representation
     contained in the third paragraph of Section 1(a)(i) hereof.

          (b) Termination of Agreement. If this Agreement is terminated by the
     Representatives in accordance with the provisions of Section 5 or Section
     9(a)(i) hereof, the Fund or the Adviser shall reimburse, or arrange for an
     affiliate to reimburse, the Underwriters for all of their out of pocket
     expenses, including reasonable fees and disbursements of counsel for the
     Underwriters. If this Agreement is terminated for any reason other than by
     the Representatives in accordance with the provisions of Section 5 or
     Section 9(a)(i) hereof, the Fund or the Adviser shall reimburse, or arrange
     for an affiliate to reimburse, the Underwriters for all of their out of
     pocket expenses, including reasonable fees and disbursements of counsel for
     the Underwriters up to a maximum reimbursement of $________.

     Section 5. Conditions of Underwriters' Obligations. The obligations of the
several Underwriters hereunder are subject to the accuracy of the
representations and warranties of the Fund and the Adviser contained in Section
1 hereof or in certificates of any officer of the Fund or the Adviser delivered
pursuant to the provisions hereof, to the performance by the Fund and the
Adviser of their respective covenants and other obligations hereunder, and to
the following further conditions:

          (a) Effectiveness of Registration Statement. The Registration
     Statement, including any Rule 462(b) Registration Statement, has become
     effective and at Closing Time no stop order suspending the effectiveness of
     the Registration Statement shall have been issued under the 1933 Act, no
     notice or order pursuant to Section 8(e) of the 1940 Act shall have been
     issued, and no proceedings with respect to either shall have been initiated
     or, to the Fund's knowledge, threatened by the Commission, and any request
     on the part of the Commission for additional information shall have been
     complied with to the reasonable satisfaction of counsel to the
     Underwriters. A prospectus containing the Rule 430A Information shall have
     been filed with the Commission in accordance with Rule 497 (or a
     post-effective



     amendment providing such information shall have been filed and declared
     effective in accordance with the requirements of Rule 430A)

          (b) Opinions of Counsel.

               (i) Opinion of Counsel for the Fund and the Adviser. At Closing
          Time, the Representatives shall have received the favorable opinions,
          dated as of Closing Time, from Blackwell Sanders Peper Martin LLP,
          counsel for the Fund and Advisor and Vedder, Price, Kaufman &
          Kammholz, P.C., special counsel for the Fund, together with signed and
          reproduced copies of such letters for each of the other Underwriters,
          which opinions shall be substantially similar to those opinions
          delivered on February 27, 2004, in connection with the initial public
          offering of the Fund, and to such further effect as counsel to the
          Underwriters may reasonably request. As to matters of Maryland law,
          Vedder, Price, Kaufman & Kammholz, P.C. may rely on the opinion of
          Venable LLP.

               (ii) Opinion of Counsel for the Underwriters. At Closing Time,
          the Representatives shall have received the favorable opinion, dated
          as of Closing Time, from Kaye Scholer LLP, counsel for the
          Underwriters, together with signed and reproduced copies of such
          letters for each of the other Underwriters, which opinion shall be in
          form and substance satisfactory to the Representatives.

          (c) Officers' Certificates. At Closing Time, there shall not
     have been, since the date hereof or since the respective dates as of which
     information is given in the Prospectus or the General Disclosure Package,
     any material adverse change in the condition, financial or otherwise, or in
     the earnings, business affairs or business prospects of the Fund, whether
     or not arising in the ordinary course of business, and the Representatives
     shall have received a certificate of a duly authorized officer of the Fund
     and of the chief financial or chief accounting officer of the Fund and of
     the President or a Vice President or Managing Director of the Adviser,
     dated as of Closing Time, to the effect that (i) there has been no such
     material adverse change, (ii) the representations and warranties in
     Sections l(a) and (b) hereof are true and correct with the same force and
     effect as though expressly made at and as of Closing Time, (iii) the Fund
     or the Adviser, as applicable, has complied with all agreements and
     satisfied all conditions on its part to be performed or satisfied at or
     prior to Closing Time, and (iv) no stop order suspending the effectiveness
     of the Registration Statement, or order of suspension or revocation of
     registration pursuant to Section 8(e) of the 1940 Act, has been issued and
     no proceedings for any such purpose have been instituted or are pending or,
     to the knowledge of the Fund or the Adviser, contemplated by the
     Commission.

          (d) Accountant's Comfort Letter. At the time of the execution of this
     Agreement, the Representatives shall have received from Ernst & Young LLP
     ("E&Y") a letter dated such date, in form and substance satisfactory to the
     Representatives, containing statements and information of the type
     ordinarily included in accountants' "comfort letters" to underwriters with
     respect to the financial statements and certain financial information
     contained in the Registration Statement, the General Disclosure Package and
     the Prospectus.

          (e) Bring-Down Comfort Letter. At Closing Time, the Representatives
     shall have received from E&Y a letter, dated as of Closing Time, to the
     effect that they reaffirm the statements made in the letter furnished
     pursuant to subsection (d) of this Section, except that the specified date
     referred to shall be a date not more than three (3) business days prior to
     Closing Time.

          (f) Approval of Listing. At Closing Time, the Shares shall have been
     approved for listing on the NYSE, subject only to official notice of
     issuance.



          (g) No Objection. [INTENTIONALLY RESERVED].

          (h) Conditions to Purchase of Option Shares. In the event that the
     Underwriters exercise their option provided in Section 2(b) hereof to
     purchase all or any portion of the Option Shares, the representations and
     warranties of the Fund contained herein and the statements in any
     certificates furnished by the Fund hereunder shall be true and correct as
     of each Date of Delivery and, at the relevant Date of Delivery, the
     Representatives shall have received:

               (i) Officers' Certificates. Certificates, dated such Date of
          Delivery, of a duly authorized officer of the Fund and of the chief
          financial or chief accounting officer of the Fund and of the President
          or a Vice President or Managing Director of the Adviser confirming
          that the information contained in the certificate delivered by each of
          them at the Closing Time pursuant to Section 5(c) hereof remains true
          and correct as of such Date of Delivery.

               (ii) Opinions of Counsel.

                    a) Opinions of Counsel for the Fund and the Adviser. The
               favorable opinions of Blackwell Sanders Peper Martin LLP, counsel
               for the Fund and the Adviser and Vedder, Price, Kaufman &
               Kammholz, P.C., special counsel for the Fund, dated such Date of
               Delivery, relating to the Option Shares to be purchased on such
               Date of Delivery and otherwise to the same effect as the opinion
               required by Section 5(b)(i) hereof, including reliance by Vedder,
               Price, Kaufman & Kammholz, P.C. on Venable LLP as to matters of
               Maryland law.

                    b) Opinion of Counsel for the Underwriters. The favorable
               opinion of Kaye Scholer LLP, counsel for the Underwriters, dated
               such Date of Delivery, relating to the Option Shares to be
               purchased on such Date of Delivery and otherwise to the same
               effect as the opinion required by Section 5(b)(ii) hereof.

               (iii) Bring-Down Comfort Letter. A letter from E&Y, in form and
          substance satisfactory to the Representatives and dated such Date of
          Delivery, substantially in the same form and substance as the letter
          furnished to the Representatives pursuant to Section 5(e) hereof,
          except that the "specified date" in the letter furnished pursuant to
          this paragraph shall be a date not more than five (5) days prior to
          such Date of Delivery.

          (i) Maintenance of Rating. Since the execution of this Agreement,
     there shall not have been any decrease in the rating of any of the Fund's
     securities by any "nationally recognized statistical rating organization"
     (as defined for purposes of Rule 436(g) under the 1933 Act) or any notice
     given of any intended or potential decrease in any such rating or of a
     possible change in any such rating that does not indicate the direction of
     the possible change.

          (j) Additional Documents. At Closing Time and at each Date of
     Delivery, counsel for the Underwriters shall have been furnished with such
     documents and opinions as they may reasonably require for the purpose of
     enabling them to pass upon the issuance and sale of the Shares as herein
     contemplated, or in order to evidence the accuracy of any of the
     representations or warranties, or the fulfillment of any of the conditions
     herein contained; and all proceedings taken by the Fund and the Adviser in
     connection with the organization and registration of the Fund under the
     1940 Act and the issuance and sale of the Shares as herein contemplated
     shall be reasonably satisfactory in form and substance to the
     Representatives and counsel for the Underwriters.

          (k) Termination of Agreement. If any condition specified in this
     Section shall not have been fulfilled when and as required to be fulfilled,
     this Agreement, or, in the case of any condition to



     the purchase of Option Shares, on a Date of Delivery which is after the
     Closing Time, the obligations of the several Underwriters to purchase the
     relevant Option Shares, may be terminated by the Representatives by notice
     to the Fund at any time at or prior to Closing Time or such Date of
     Delivery, as the case may be, and such termination shall be without
     liability of any party to any other party except as provided in Section 4
     and except that Sections 1, 6, 7, 8 and 13 shall survive any such
     termination and remain in full force and effect.

     Section 6. Indemnification.

          (a) Indemnification of Underwriters. The Fund and the Adviser agree,
     jointly and severally, to indemnify and hold harmless each Underwriter and
     each person, if any, who controls any Underwriter within the meaning of
     Section 15 of the 1933 Act or Section 20 of the 1934 Act, and any director,
     officer, employee or affiliate thereof as follows:

               (i) against any and all loss, liability, claim, damage and
          expense whatsoever, as incurred, arising out of any untrue statement
          or alleged untrue statement of a material fact contained in the
          Registration Statement (or any amendment thereto), including the Rule
          430A Information or the omission or alleged omission therefrom of a
          material fact required to be stated therein or necessary to make the
          statements therein not misleading or arising out of any untrue
          statement or alleged untrue statement of a material fact included in
          any preliminary prospectus, any Rule 482 Statement or the Prospectus
          (or any amendment or supplement thereto), or the omission or alleged
          omission therefrom of a material fact necessary in order to make the
          statements therein, in the light of the circumstances under which they
          were made, not misleading;

               (ii) against any and all loss, liability, claim, damage and
          expense whatsoever, as incurred, to the extent of the aggregate amount
          paid in settlement of any litigation, or any investigation or
          proceeding by any governmental agency or body, commenced or
          threatened, or of any claim whatsoever based upon any such untrue
          statement or omission, or any such alleged untrue statement or
          omission; provided that (subject to Section 6(e) below) any such
          settlement is effected with the written consent of the Fund; and

               (iii) against any and all expense whatsoever, as incurred
          (including the fees and disbursements of counsel chosen by
          _____________), reasonably incurred in investigating, preparing or
          defending against any litigation, or any investigation or proceeding
          by any governmental agency or body, commenced or threatened, or any
          claim whatsoever based upon any such untrue statement or omission, or
          any such alleged untrue statement or omission, to the extent that any
          such expense is not paid under (i) or (ii) above; provided, however,
          that this indemnity agreement shall not apply to any loss, liability,
          claim, damage or expense to the extent arising out of any untrue
          statement or omission or alleged untrue statement or omission made in
          reliance upon and in conformity with written information furnished to
          the Fund or the Adviser by any Underwriter through _____________
          expressly for use in the Registration Statement (or any amendment
          thereto), including the Rule 430A Information, or any preliminary
          prospectus, any Rule 482 Statement or the Prospectus (or any amendment
          or supplement thereto).

          (b) Indemnification of Fund, Adviser, Directors and Officers. Each
     Underwriter severally agrees to indemnify and hold harmless the Fund and
     the Adviser, their respective directors, each of the Fund's officers who
     signed the Registration Statement, and each person, if any, who controls
     the Fund or the Adviser within the meaning of Section 15 of the 1933 Act or
     Section 20 of the 1934 Act against any and all loss, liability, claim,
     damage and expense described in the indemnity contained in subsection (a)
     of this Section, as incurred, but only with respect to untrue statements or
     omissions, or alleged untrue statements or omissions, made in the
     Registration Statement (or any amendment thereto), including the Rule 430A
     Information, or any preliminary prospectus or the Prospectus (or any
     amendment



     or supplement thereto) in reliance upon and in conformity with written
     information furnished to the Fund or the Adviser by such Underwriter
     through _____________ expressly for use in the Registration Statement (or
     any amendment thereto) or such preliminary prospectus or the Prospectus (or
     any amendment or supplement thereto).

          (c) Indemnification for Marketing Materials. In addition to the
     foregoing indemnification, the Fund and the Adviser also agree, jointly and
     severally, to indemnify and hold harmless each Underwriter and each person,
     if any, who controls any Underwriter within the meaning of Section 15 of
     the 1933 Act or Section 20 of the 1934 Act, against any and all loss,
     liability, claim, damage and expense described in the indemnity contained
     in Section 6(a), as limited by the proviso set forth therein, with respect
     to any Sales Material in the form approved by the Fund, the Adviser and the
     Representatives for use by the Underwriters and securities firms to whom
     the Fund or the Adviser shall have disseminated materials in connection
     with the public offering of the Shares.

          (d) Actions Against Parties; Notification. Each indemnified party
     shall give notice as promptly as reasonably practicable to each
     indemnifying party of any action commenced against it in respect of which
     indemnity may be sought hereunder, but failure to so notify an indemnifying
     party shall not relieve such indemnifying party from any liability
     hereunder to the extent it is not materially prejudiced as a result thereof
     and in any event shall not relieve it from any liability which it may have
     otherwise than on account of this indemnity agreement. In the case of
     parties indemnified pursuant to Section 6(a) above, counsel to the
     indemnified parties shall be selected by _____________, and, in the case of
     parties indemnified pursuant to Section 6(b) above, counsel to the
     indemnified parties shall be selected by the Fund and the Adviser. An
     indemnifying party may participate at its own expense in the defense of any
     such action; provided, however, that counsel to the indemnifying party
     shall not (except with the consent of the indemnified party) also be
     counsel to the indemnified party. In no event shall the indemnifying
     parties be liable for fees and expenses of more than one counsel (in
     addition to any local counsel) separate from their own counsel for all
     indemnified parties in connection with any one action or separate but
     similar or related actions in the same jurisdiction arising out of the same
     general allegations or circumstances. No indemnifying party shall, without
     the prior written consent of the indemnified parties, settle or compromise
     or consent to the entry of any judgment with respect to any litigation, or
     any investigation or proceeding by any governmental agency or body,
     commenced or threatened, or any claim whatsoever in respect of which
     indemnification or contribution could be sought under this Section 6 or
     Section 7 hereof (whether or not the indemnified parties are actual or
     potential parties thereto), unless such settlement, compromise or consent
     (i) includes an unconditional release of each indemnified party from all
     liability arising out of such litigation, investigation, proceeding or
     claim and (ii) does not include a statement as to or an admission of fault,
     culpability or a failure to act by or on behalf of any indemnified party.

          (e) Settlement Without Consent if Failure to Reimburse. If at any time
     an indemnified party shall have requested an indemnifying party to
     reimburse the indemnified party for fees and expenses of counsel, such
     indemnifying party agrees that it shall be liable for any settlement of the
     nature contemplated by Section 6(a)(ii) effected without its written
     consent if (i) such settlement is entered into more than 45 days after
     receipt by such indemnifying party of the aforesaid request, (ii) such
     indemnifying party shall have received notice of the terms of such
     settlement at least 30 days prior to such settlement being entered into and
     (iii) such indemnifying party shall not have reimbursed such indemnified
     party in accordance with such request prior to the date of such settlement.

          (f) Limitations on Indemnification. Any indemnification by the Fund
     shall be subject to the requirements and limitations of Section 17(i) of
     the 1940 Act and 1940 Act Release 11330.



     Section 7. Contribution. If the indemnification provided for in Section 6
hereof is for any reason unavailable to or insufficient to hold harmless an
indemnified party in respect of any losses, liabilities, claims, damages or
expenses referred to therein, then each indemnifying party shall contribute to
the aggregate amount of such losses, liabilities, claims, damages and expenses
incurred by such indemnified party, as incurred, (i) in such proportion as is
appropriate to reflect the relative benefits received by the Fund and the
Adviser on the one hand and the Underwriters on the other hand from the offering
of the Shares pursuant to this Agreement or (ii) if the allocation provided by
clause (i) is not permitted by applicable law, in such proportion as is
appropriate to reflect not only the relative benefits referred to in clause (i)
above but also the relative fault of the Fund and the Adviser on the one hand
and of the Underwriters on the other hand in connection with the statements or
omissions which resulted in such losses, liabilities, claims, damages or
expenses, as well as any other relevant equitable considerations.

     The relative benefits received by the Fund and the Adviser on the one hand
and the Underwriters on the other hand in connection with the offering of the
Shares pursuant to this Agreement shall be deemed to be in the same respective
proportions as the total net proceeds from the offering of the Shares pursuant
to this Agreement (before deducting expenses) received by the Fund and the total
underwriting discount received by the Underwriters (whether from the Fund or
otherwise), in each case as set forth on the cover of the Prospectus, bear to
the aggregate public offering price of the Shares as set forth on such cover.

     The relative fault of the Fund and the Adviser on the one hand and the
Underwriters on the other hand shall be determined by reference to, among other
things, whether any such untrue or alleged untrue statement of a material fact
or omission or alleged omission to state a material fact relates to information
supplied by the Fund or the Adviser or by the Underwriters and the parties'
relative intent, knowledge, access to information and opportunity to correct or
prevent such statement or omission.

     The Fund, the Adviser and the Underwriters agree that it would not be just
and equitable if contribution pursuant to this Section 7 were determined by pro
rata allocation (even if the Underwriters were treated as one entity for such
purpose) or by any other method of allocation which does not take account of the
equitable considerations referred to above in this Section 7. The aggregate
amount of losses, liabilities, claims, damages and expenses incurred by an
indemnified party and referred to above in this Section 7 shall be deemed to
include any legal or other expenses reasonably incurred by such indemnified
party in investigating, preparing or defending against any litigation, or any
investigation or proceeding by any governmental agency or body, commenced or
threatened, or any claim whatsoever based upon any such untrue or alleged untrue
statement or omission or alleged omission.

     Notwithstanding the provisions of this Section 7, no Underwriter shall be
required to contribute any amount in excess of the amount by which the total
price at which the Shares underwritten by it and distributed to the public were
offered to the public exceeds the amount of any damages which such Underwriter
has otherwise been required to pay by reason of any such untrue or alleged
untrue statement or omission or alleged omission. No person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the 1933 Act) shall be
entitled to contribution from any person who was not guilty of such fraudulent
misrepresentation.

     For purposes of this Section 7, each person, if any, who controls an
Underwriter within the meaning of Section 15 of the 1933 Act or Section 20 of
the 1934 Act shall have the same rights to contribution as such Underwriter, and
each director of the Fund and each director of the Adviser, respectively, each
officer of the Fund who signed the Registration Statement, and each person, if
any, who controls the Fund or the Adviser, within the meaning of Section 15 of
the 1933 Act or Section 20 of the 1934 Act shall have the same rights to
contribution as the Fund and the Adviser, respectively. The



Underwriters' respective obligations to contribute pursuant to this Section 7
are several in proportion to the number of Primary Shares set forth opposite
their respective names in Schedule A hereto and not joint.

     Any contribution by the Fund shall be subject to the requirements and
limitations of Section 17(i) of the 1940 Act and 1940 Act Release 11330.

     Section 8. Representations and Warranties To Survive Delivery. All
representations, warranties and agreements contained in this Agreement or in
certificates of officers of the Fund or the Adviser submitted pursuant hereto,
shall remain operative and in full force and effect, regardless of any
investigation made by or on behalf of any Underwriter or controlling person, or
by or on behalf of the Fund or the Adviser, and shall survive delivery of the
Shares to the Underwriters.

     Section 9. Termination of Agreement.

          (a) Termination; General. The Representatives may terminate this
     Agreement, by notice to the Fund, at any time at or prior to Closing Time
     (i) if there has been, since the time of execution of this Agreement or
     since the respective dates as of which information is given in the
     Prospectus or General Disclosure Package, any material adverse change in
     the condition, financial or otherwise, or in the earnings, business affairs
     or business prospects of the Fund or the Adviser, whether or not arising in
     the ordinary course of business, or (ii) if there has occurred any material
     adverse change in the financial markets in the United States or the
     international financial markets, any material outbreak of hostilities or
     material escalation thereof or other calamity or crisis or any change or
     development involving a prospective change in national or international
     political, financial or economic conditions, in each case the effect of
     which is such as to make it, in the judgment of the Representatives,
     impracticable or inadvisable to market the Shares or to enforce contracts
     for the sale of the Shares, or (iii) if trading in the Common Shares of the
     Fund has been suspended or materially limited by the Commission or the
     NYSE, or if trading generally on the American Stock Exchange or in the
     NASDAQ National Market has been suspended or materially limited, or minimum
     or maximum prices for trading have been fixed, or maximum ranges for prices
     have been required, by any of said exchanges or by such system or by order
     of the Commission, the NASD or any other governmental authority, or a
     material disruption has occurred in commercial banking or securities
     settlement or clearance services in the United States, or (iv) if a banking
     moratorium has been declared by either Federal or Kansas authorities.

          (b) Liabilities. If this Agreement is terminated pursuant to this
     Section 9, such termination shall be without liability of any party to any
     other party except as provided in Section 4 hereof, and provided further
     that Sections 1, 6, 7, 8 and 13 shall survive such termination and remain
     in full force and effect.

     Section 10. Default by One or More of the Underwriters. If one or more of
the Underwriters shall fail at Closing Time or any Date of Delivery to purchase
the Shares which it or they are obligated to purchase under this Agreement (the
"DEFAULTED SHARES"), the Representatives shall have the right, within 24 hours
thereafter, to make arrangements for one or more of the non-defaulting
Underwriters, or any other underwriters, to purchase all, but not less than all,
of the Defaulted Shares in such amounts as may be agreed upon and upon the terms
herein set forth; if, however, the Representatives shall not have completed such
arrangements within such 24-hour period, then:

          (a) if the number of Defaulted Shares does not exceed 10% of the
     number of Shares to be purchased on such date, each of the non-defaulting
     Underwriters shall be obligated, severally and not jointly, to purchase the
     full amount thereof in the proportions that their respective underwriting
     obligations hereunder bear to the underwriting obligations of all
     non-defaulting Underwriters, or



          (b) if the number of Defaulted Shares exceeds 10% of the number of
     Shares to be purchased on such date, this Agreement or, with respect to any
     Date of Delivery which occurs after the Closing Time, the obligation of the
     Underwriters to purchase and of the Fund to sell the Option Shares to be
     purchased and sold on such Date of Delivery, shall terminate without
     liability on the part of any non-defaulting Underwriter.

     No action taken pursuant to this Section shall relieve any defaulting
Underwriter from liability in respect of its default.

     In the event of any such default which does not result in a termination of
this Agreement or, in the case of a Date of Delivery which is after the Closing
Time, which does not result in a termination of the obligation of the
Underwriters to purchase and the Fund to sell the relevant Option Shares, as the
case may be, either the Representatives or the Fund shall have the right to
postpone Closing Time or the relevant Date of Delivery, as the case may be, for
a period not exceeding seven (7) days in order to effect any required changes in
the Registration Statement or Prospectus or in any other documents or
arrangements. As used herein, the term "Underwriter" includes any person
substituted for an Underwriter under this Section 10.

     Section 11. Notices. All notices and other communications hereunder shall
be in writing and shall be deemed to have been duly given if mailed or
transmitted by any standard form of telecommunication. Notices to the
Underwriters shall be directed to the Representatives, c/o
______________________________, attention of ________________, Managing
Director; and notices to the Fund or the Adviser shall be directed, as
appropriate, to the office of the Adviser, 10801 Mastin Boulevard, Suite 222,
Overland Park, Kansas 66210, attention of Management Committee.

     Section 12. No Advisory or Fiduciary Relationship. The Fund acknowledges
and agrees that (a) the purchase and sale of the Shares pursuant to this
Agreement, including the determination of the public offering price of the
Securities and any related discounts and commissions, is an arm's-length
commercial transaction between the Fund, on the one hand, and the several
Underwriters, on the other hand, (b) in connection with the offering
contemplated hereby and the process leading to such transaction each Underwriter
is and has been acting solely as a principal and is not the agent or fiduciary
of the Fund, or any of its stockholders, creditors or employees or any other
party, (c) no Underwriter has assumed or will assume an advisory or fiduciary
responsibility in favor of the Fund with respect to the offering contemplated
hereby or the process leading thereto (irrespective of whether such Underwriter
has advised or is currently advising the Fund on other matters) and no
Underwriter has any obligation to the Fund with respect to the offering
contemplated hereby except the obligations expressly set forth in this
Agreement, (d) the Underwriters and their respective affiliates may be engaged
in a broad range of transactions that involve interests that differ from those
of the Fund, and (e) the Underwriters have not provided legal, accounting,
regulatory or tax advice with respect to the offering contemplated hereby and
the Fund has consulted its own respective legal, accounting, regulatory and tax
advisors to the extent it deemed appropriate.

     Section 13. Parties. This Agreement shall each inure to the benefit of and
be binding upon the Underwriters, the Fund, the Adviser and their respective
partners and successors. Nothing expressed or mentioned in this Agreement is
intended or shall be construed to give any person, firm or corporation, other
than the Underwriters, the Fund, the Adviser and their respective successors and
the controlling persons and officers and directors referred to in Sections 6 and
7 and their heirs and legal representatives, any legal or equitable right,
remedy or claim under or in respect of this Agreement or any provision herein
contained. This Agreement and all conditions and provisions hereof are intended
to be for the sole and exclusive benefit of the Underwriters, the Fund, the
Adviser and their respective partners and successors, and said controlling
persons and officers, directors and their heirs and legal representatives,



and for the benefit of no other person, firm or corporation. No purchaser of
Shares from any Underwriter shall be deemed to be a successor by reason merely
of such purchase.

     Section 14. Governing Law and Time. THIS AGREEMENT SHALL BE GOVERNED BY AND
CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK APPLICABLE TO
AGREEMENTS MADE AND TO BE PERFORMED IN SAID STATE. UNLESS OTHERWISE EXPLICITLY
PROVIDED, SPECIFIED TIMES OF DAY REFER TO CENTRAL STANDARD TIME.

     Section 15. Effect of Headings. The Article and Section headings herein are
for convenience only and shall not affect the construction hereof.





     If the foregoing is in accordance with your understanding of our agreement,
please sign and return to us a counterpart hereof, whereupon this instrument,
along with all counterparts, will become a binding agreement among the
Underwriters, the Fund and the Adviser in accordance with its terms.

                                       Very truly yours,


                                       TORTOISE ENERGY CAPITAL CORPORATION


                                       By ____________________________________
                                       Name:
                                       Title:


                                       TORTOISE CAPITAL ADVISORS, LLC


                                       By ____________________________________
                                       Name:
                                       Title:


CONFIRMED AND ACCEPTED,
as of the date first above written:

___________________________________

By:________________________________
     Authorized Signatory



___________________________________

By:________________________________
     Authorized Signatory


Each for itself and collectively as Representatives of the other Underwriters
named in Schedule A hereto.



                                   SCHEDULE A

                                                                     Number of
       Name of Underwriter                                        Primary Shares
--------------------------------------------------------------------------------







   TOTAL...........................................................____________

                                                                   ============

                                       25





                                   SCHEDULE B

                       Tortoise Energy Capital Corporation
                            __________ Common Shares

     1 The public offering price per share for the Shares, determined as
provided in said Section 2, shall be $______.

     2 The purchase price per share for the Shares to be paid by the several
Underwriters shall be $______, being an amount equal to the public offering
price set forth above less $____ per share; provided that the purchase price per
share for any Option Shares purchased upon the exercise of the over-allotment
option described in Section 2(b) shall be reduced by an amount per share equal
to any dividends or distributions declared by the Fund and payable on the
Primary Shares but not payable on the Option Shares.










                                       26








                                   SCHEDULE C

                            Price Per Share = $_____







                                       27



                                   SCHEDULE D

        The Investor Guide dated _________ _______ entitled "Add-On Offering
of Common Stock (NYSE: TYY)"






                                       28